Sympathetic-renal interaction in chronic arterial pressure control.
The effects of neonatal sympathectomy of donors or recipients on posttransplantation arterial pressure were investigated in spontaneously hypertensive rats (SHR) by renal transplantation experiments. Conscious mean arterial pressure (MAP) and renal vascular resistance were 136 +/- 1 mmHg and 15.5 +/- 1.2 mmHg x ml(-1) x min x g in sympathectomized SHR (n = 8) vs. 158 +/- 4 mmHg (P < 0.001) and 20.8 +/- 1.1 mmHg x ml(-1) x min x g (P < 0.05) in controls (n = 10). Seven weeks after transplantation of a kidney from neonatally sympathectomized SHR donors, MAP in SHR recipients (n = 10) was 20 mmHg lower than in controls transplanted with a kidney from hydralazine-treated SHR (n = 10) (P < 0.05) associated with reduced sodium sensitivity of MAP. Neonatal sympathectomy also lowered MAP in F1-hybrids (F1H; SHR x Wistar-Kyoto rats). Within 6 wk after transplantation, renal grafts from untreated SHR increased MAP by 20 mmHg in sympathectomized F1H (n = 10) and by 35 mmHg in sham-treated F1H (n = 8) (P < 0.05). Neonatal sympathectomy induces chronic changes in SHR kidney function leading to a MAP reduction even when extrarenal sympathetic tone is restored. Generalized reduction in sympathetic tone resets the kidney-fluid system to reduced MAP and blunts the extent of arterial pressure rise induced by an SHR kidney graft.
Grisk
Olaf
O
Department of Physiology, Ernst-Moritz-Arndt-University, D-17487 Greifswald, Germany. grisko@uni-greifswald.de
Rose
Hans-Joachim
HJ
Lorenz
Gerd
G
Rettig
Rainer
R
D000818:Animals; D000831:Animals, Newborn; D001161:Arteriosclerosis / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D001835:Body Weight / Q000502:physiology; D003404:Creatinine / Q000097:blood; D003433:Crosses, Genetic; D018450:Disease Progression; D004231:Diuresis / Q000187:drug effects; D004326:Drinking; D006145:Guanethidine; D006339:Heart Rate; D006830:Hydralazine / Q000494:pharmacology; D006977:Hypertension, Renal / Q000209:etiology / Q000503:physiopathology*; D007668:Kidney / Q000187:drug effects / Q000294:innervation / Q000473:pathology / Q000503:physiopathology*; D016030:Kidney Transplantation / Q000009:adverse effects; D008297:Male; D009318:Natriuresis / Q000187:drug effects; D009638:Norepinephrine / Q000097:blood; D009929:Organ Size / Q000502:physiology; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D012982:Sodium, Dietary / Q000494:pharmacology; D013563:Sympathectomy, Chemical; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000503:physiopathology*; D013995:Time; D014508:Urea / Q000097:blood; D014655:Vascular Resistance / Q000187:drug effects
D012982:Sodium, Dietary; D006830:Hydralazine; D014508:Urea; D003404:Creatinine; D009638:Norepinephrine; D006145:Guanethidine